Acquisition Synergy XVIVO absorbed Organ Assist, expanding capabilities in oxygenated machine perfusion across kidney, liver, and lung applications. This creates cross-selling opportunities to current and former Organ Assist customers and positions XVIVO to offer a broader organ perfusion solution portfolio.

Training Ecosystem Organ Assist Academy offers tailored theoretical and practical training on device application and maintenance. Leverage this training platform to onboard new hospital accounts, accelerate adoption, and reduce implementation risk for prospective customers.

Global Trials Footprint Active participation in multicenter trials and ongoing dissemination at major conferences (ISHLT) signals clinical credibility. Use trial data and thought leadership to engage transplant centers seeking evidence of improved organ viability and workflow efficiency.

CE Certified Advantage All devices are CE approved with pulsatile flow capabilities and organ-specific preset settings. Market to hospitals prioritizing certified, compliant, ready-to-deploy perfusion solutions that minimize training burden and risk.

Small Team, Niche Focus With a small employee base yet a specialized product line, there is an opportunity to target high-value transplant centers and regional networks through dedicated, high-touch sales motions and strategic partnerships that leverage the Organ Assist Academy.